If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCharacter Regulatory News (CCT)

Share Price Information for Character (CCT)

Share Price is delayed by 15 minutes
Get Live Data
290.00    0.00 (0.00%)
Bid:
280.00
Ask:
300.00
Spread: 20.00 (7.143%)
Market Cap: £50.46m
CCT Live PriceLast checked at - London Stock Exchange

Intraday Character Share Chart

Trading Update

11 Apr 2025 07:00

RNS Number : 6015E
Character Group PLC (The)
11 April 2025
 

 

 

Friday, 11 April 2025

 

 

The Character Group plc

("Character", the "Company" or the "Group")

Trading update

 

The recent unilateral imposition by the USA of trade tariffs on imports, particularly from China, and the escalating retaliatory measures being adopted have greatly impacted global economic stability in a very short space of time. 

 

The Board's visibility for forecasting sales to USA (which were c.20% of Group turnover in the last financial year) and its ability to assess the financial implications for the Group have been considerably obscured by these events. Consequently, the effect of the imposition of the trade tariffs will be felt in the second half by the Group and, as a result, the Company is withdrawing the market guidance for the year ending 31 August 2025. Despite this, the Board remains confident that the Group will be profitable for the current financial year as a whole.

 

The review of the Company's H1 results, which are due to be published in mid-May, is not yet complete, however, all indications at this time are that, in accordance with market expectations, the trading results to February 2025 will be in line with the first-half performance in the prior year (HY 2024 profit before tax and highlighted items: £2.1m).

 

The Company continues to have a strong balance sheet with healthy cash balances and the Board is confident that it can ride out this storm. As we gain a clearer picture of the global economic landscape emerging, we will update shareholders further.

 

 

 

 

 

Enquiries to:

The Character Group plc

Jon Diver, Joint Managing Director

Kiran Shah, Joint Managing Director

Hamun Shah, Group Finance Director

Office: +44 (0) 208 329 3377

 

Panmure Liberum (Nominated Adviser and Joint Broker)

Atholl Tweedie, Investment Banking

Rupert Dearden, Corporate Broking

Tel: +44 (0) 20 7886 2500

Allenby Capital Limited (Joint Broker)

Nick Athanas, Corporate Finance

Amrit Nahal / Tony Quirke, Sales & Corporate Broking

Tel: +44 (0) 20 3328 5656

 

TooleyStreet Communications Limited (Investor and media relations)

Fiona Tooley

Tel: +44 (0) 7785 703523

Email: fiona@tooleystreet.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSFFEFSEISESL
Date   Source Headline
31st Dec 20139:00 amRNSTotal Voting Rights
23rd Dec 20133:55 pmRNSDirector/PDMR Shareholding
18th Dec 20134:56 pmRNSAnnual Financial Report - August 2013
16th Dec 20133:56 pmRNSTransaction in Own Shares
13th Dec 20136:15 pmRNSHolding(s) in Company
13th Dec 20136:00 pmRNSHolding(s) in Company
11th Dec 20135:55 pmRNSTransaction in Own Shares
10th Dec 20135:21 pmRNSDirector/PDMR Shareholding
5th Dec 20132:10 pmRNSTransaction in Own Shares
28th Nov 20137:00 amRNSAnnual Results-year ended 31 August 2013
22nd Nov 20135:08 pmRNSNotice of Results - year ended 31 August 2013
6th Nov 20132:00 pmRNSNon Regulatory Announcement
5th Nov 201312:19 pmRNSCompany Secretary Appointment
30th Sep 20134:20 pmRNSTotal Voting Rights
26th Sep 201312:34 pmRNSTransaction in Own Shares
23rd Sep 20139:25 amRNSTransaction in Own Shares
16th Sep 20133:44 pmRNSHolding(s) in Company
13th Sep 20136:10 pmRNSDirector/PDMR Shareholding
13th Sep 20134:30 pmRNSDirector/PDMR Shareholding
6th Sep 20137:00 amRNSTrading update
2nd Sep 201311:48 amRNSTotal Voting Rights
31st Jul 201312:47 pmRNSTotal Voting Rights
28th Jun 20133:16 pmRNSDirector/PDMR Shareholding
28th Jun 20133:15 pmRNSTotal Voting Rights
6th Jun 20131:31 pmRNSTotal Voting Rights
2nd May 20137:00 amRNSHalf Yearly Report -period to February 2013
29th Apr 20136:08 pmRNSNotice of Half-year Results
11th Mar 20139:57 amRNSBlocklisting Interim Review
5th Mar 20137:58 amRNSTotal Voting Rights
22nd Feb 20134:17 pmRNSDirector/PDMR Shareholding
31st Jan 20133:05 pmRNSTotal Voting Rights
29th Jan 201312:12 pmRNSAnnual General Meeting - Result
29th Jan 20137:00 amRNSTrading Update
17th Jan 20132:32 pmRNSTransaction in Own Shares
8th Jan 20137:00 amRNSTransaction in Own Shares
3rd Jan 20138:00 amRNSTransaction in Own Shares
2nd Jan 201310:08 amRNSTotal Voting Rights
2nd Jan 201310:07 amRNSTransaction in Own Shares
24th Dec 20129:43 amRNSHolding(s) in Company
21st Dec 20123:01 pmRNSExercise of options by Directors
19th Dec 201210:15 amRNSAnnual Financial Report - 31 August 2012
4th Dec 20127:00 amRNSPreliminary Results -year ended 31 August 2012
27th Nov 20122:36 pmRNSNotice of Results
9th Nov 20123:16 pmRNSTrading Update
1st Oct 20123:10 pmRNSTotal Voting Rights
28th Sep 20123:35 pmRNSBlocklisting Interim Review
3rd Sep 201212:49 pmRNSTotal Voting Rights
2nd Aug 201212:17 pmRNSTotal Voting Rights
27th Jul 20123:57 pmRNSTransaction in Own Shares
27th Jul 20127:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.